Baird Medical Investment Holdings Limited Capital Reinvestment Ratio
Baird Medical Investment Holdings Limited capital reinvestment ratio. Baird Medical Investment Holdings Limited (BDMD) has a Capital Reinvestment Ratio of 1.97x as of June 2023, meaning it reinvests 2% of its operating cash flow ($642.95K) in capital expenditures ($1.26 Million). See Baird Medical Investment Holdings Limite (BDMD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Baird Medical Investment Holdings Limited (2019–2022)
Capital reinvestment ratio of Baird Medical Investment Holdings Limited from 2019 to 2022. This chart tracks Baird Medical Investment Holdings Limited's Capital Reinvestment Ratio across 4 annual periods. See Baird Medical Investment Holdings Limite (BDMD) flexibility index to measure the company's free cash flow as a share of total liabilities.
Baird Medical Investment Holdings Limited Capital Reinvestment Ratio by Year (2019–2022)
Baird Medical Investment Holdings Limited capital reinvestment ratio by year from 2019 to 2022. For the full cash flow conversion analysis, see BDMD cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 12.25x | $485.97K | $5.95 Million | ▲ +4539.9% |
| 2021 | 0.26x | $5.26 Million | $1.39 Million | ▲ +57.4% |
| 2020 | 0.17x | $3.91 Million | $655.35K | ▼ -24.8% |
| 2019 | 0.22x | $4.41 Million | $983.78K | — |